The DOI matches its Crossref record.
Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha
Abstract
Current evidence indicates that endogenously produced peptide cytokines, most notably TNF-alpha and IL-1, mediate the lethality of experimental endotoxemia. Because circulating serum levels of IFN-gamma can be detected soon after TNF-alpha and IL-1 in response to endotoxin, we investigated the role of IFN-gamma in endotoxin and TNF-alpha lethality. Specific neutralizing antibodies to murine TNF-alpha (anti-TNF-alpha Ab) or murine IFN gamma (anti-IFN-gamma Ab) produced in our laboratory protected mice against the lethality of Escherichia coli endotoxin (LPS) administered 6 h later. Serum IFN-gamma levels 2 h after i.v. LPS were lower in mice treated with anti-TNF-alpha Ab compared to mice that received nonimmune IgG (median less than 2.5 vs 3.0 U/ml, P2 less than 0.05). In contrast, serum TNF-alpha levels 1 h after i.v. LPS peaked more than fourfold higher in mice treated with anti-IFN-gamma Ab compared to controls (median greater than 6400 vs 1405 pg/ml, p2 less than 0.05). Doses of TNF-alpha (300 micrograms/kg) and IFN-gamma (50,000 U) which were well tolerated when given individually were synergistically lethal in combination (0% lethality vs 100% lethality, P2 less than 0.001), and were associated with higher serum levels of IL-6 than with either cytokine alone. Anti-IFN-gamma Ab provided complete protection against exogenous human rTNF-alpha at the LD100 dose (1400 micrograms/kg, p2 less than 0.001), and in fact prevented lethality at doses four- to fivefold greater than the LD100 human rTNF-alpha (up to 6000 micrograms/kg). We conclude that IFN-gamma is synergistic with TNF-alpha, is essential for the lethality of LPS and TNF-alpha, and may have modulating effects on the negative control of serum levels of TNF-alpha after LPS in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The administration of recombinant cytokines (e.g., interleukin-1, interleukin-6, interleukin-12, interleukin-18, tumor necrosis factor [TNF], and interferon-γ) in animal models and for cancer treatment in humans induces severe toxic effects or lethality consistent with the central role of cytokines as mediators of hyperinflammation in cytokine storm.”
From Cytokine storm (2020) · cites this paper as [27]
Citations
Cited by
Sorted by citations
Items 201–300 of 300
Zhang, X., Feng, J., Zhu, P., & Zhao, Z. (2013) · Inflammation · doi:10.1007/s10753-013-9642-y · Cited by 17
COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective
Cavaillon, J.-M., & Osuchowski, M. F. (2021) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2021.04.003 · Cited by 17
Pahuja, M., Tran, C., Wang, H., & Yin, K. (2008) · Shock · doi:10.1097/shk.0b013e31815d0c8f · Cited by 17
Bahr, G. M., Pouillart, P., & CHEDID, L. A. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.297 · Cited by 16
Liao, F., Gu, W., Fu, X., Yuan, B., & Zhang, Y. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.10.013 · Cited by 17
Singer, J. W., Rursten, S. L., Rice, G. C., et al. (1994) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.3.6.631 · Cited by 16
Cytokines in the treatment of fungal infections
Kullberg, B. J., & Wout, J. W. V. ’. (1994) · Biotherapy · doi:10.1007/bf01878486 · Cited by 16
Myeloid autophagy genes protect mice against fatal TNF- and LPS-induced cytokine storm syndromes
Wang, Y., Sansone, A., Smirnov, A., Stallings, C. L., & Orvedahl, A. (2022) · Autophagy · doi:10.1080/15548627.2022.2116675 · Cited by 16
“…by the following: 1) becn1 ΔLyz2 mice exhibited elevated serum IFNG levels (Figure 2a); 2) genetic ablation of Ifngr1 (interferon gamma receptor 1) rescues the hypersensitivity of becn1 ΔLyz2 mice to ivTNF [15]; and, 3) IFNG is known to contribute to mortality in LPS-induced shock [43,45,68,72–75].”
The Pro-Inflammatory Cytokine Cascade
Cavaillon, J., & Adib‐Conquy, M. (2002) · Springer eBooks · doi:10.1007/978-3-642-57210-4_4 · Cited by 15
The ameliorative effects of a hypnotic bromvalerylurea in sepsis
Kikuchi, S., Nishihara, T., Kawasaki, S., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.111 · Cited by 15
Preventive effect of cyclosporin A on experimentally induced acute liver injury in rats
Wasaki, S., Sakaida, I., Uchida, K., et al. (1997) · Liver International · doi:10.1111/j.1600-0676.1997.tb00790.x · Cited by 15
Gladue, R. P., Laquerre, A. M., Magna, H. A., et al. (1994) · Cytokine · doi:10.1016/1043-4666(94)90029-9 · Cited by 15
Karki, R., Netea, M. G., Diorio, C., & Kanneganti, T. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00677-4 · Cited by 24
“TNF and IFNγ seem to be sufficient to drive cytokine storm, as intraperitoneal injection of these cytokines induces mortality in mice 2,111 and mirrors the major symptoms of cytokine storm observed in patients with COVID-19 (ref.”
Reverse Engineering the Febrile System
Shephard, A. M., Bharwani, A., Durisko, Z., & Andrews, P. W. (2016) · The Quarterly Review of Biology · doi:10.1086/689482 · Cited by 14
“Mice exposed to febrile-range temperatures display increased coexpression of IFN-γ and TNF-α within the infected peritoneal compartment (Doherty et al. 1992; Skerrett and Martin 1996), thereby enhancing pathogenic defenses at this specific site of infection.”
BackgroundGuivier, E., Bellenger, J., Sorci, G., et al. (2016) · The American Naturalist · doi:10.1086/687149 · Cited by 14
Blanqué, R., Meakin, C., Millet, S., et al. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00217-1 · Cited by 14
Interferon‐γ in healthy subjects: selective modulation of inflammatory mediators
de Metz, J., Hack, C. E., Romijn, J. A., et al. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00833.x · Cited by 14
Márquez-Velasco, R., Bojalil, R., Buelna, A., Flores-Guzmán, F., Estevez-Ramirez, J., Laguna, J., Hernández, A. M., Díaz-Quiñónez, J. A., & Paniagua-Solís, J. (2006) · Inflammation Research · doi:10.1007/s00011-006-6001-6 · Cited by 13
“Paradoxically, its exacerbated production during the septic process, together with the presence of other cytokines like IL-1b, IL-12, IL-8 and IFNg [16–25], contri butes to the development of tissue damage and multiple organ dysfunction [26].”
BackgroundCauwels, A., Brouckaert, P., Grooten, J., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2753 · Cited by 13
Innate immune response in acute critical illness: a narrative review
Stiel, L., Gaudet, A., Thietart, S., Vallet, H., Bastard, P., Voiriot, G., Oualha, M., Sarton, B., Kallel, H., Bréchot, N., et al. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01355-6 · Cited by 13
“The overacti-vation of the immune response, partly responsible for critical illness, notably results from the synergy between the various mechanisms involved in the inflammatory response leading to its disproportionate amplification [174, 175].”
BackgroundCai, J., Zhou, H., Liu, M., Zhang, D., Lv, J., Xue, H., Zhou, H., & Zhang, W. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107492 · Cited by 12
Prophylaxis of lipopolysaccharide-induced shock by α-galactosylceramide
Sireci, G., Manna, M. P. L., Liberto, D. D., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0707499 · Cited by 12
Zimecki, M., Chodaczek, G., Kocięba, M., & Kruzel, M. L. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.04.003 · Cited by 11
Dutkiewicz, J. K., Skórska, C., Burrell, R. E., et al. (2005) · PubMed · Cited by 11
Downs, T. R., Dage, R. C., & French, J. F. (1995) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(95)00042-z · Cited by 11
Neville, N., Parton, J., Harwood, J. L., & Jackson, S. K. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.12.010 · Cited by 10
Langhans, W., & Hrupka, B. J. (2003) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4615-0323-1_9 · Cited by 10
Langhans, W. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48643-1_13 · Cited by 10
Controversies surrounding current therapies for sepsis syndrome
Cavaillon, J. (1995) · Bulletin de l Institut Pasteur · doi:10.1016/0020-2452(96)81482-5 · Cited by 10
Lysophospholipid acyltransferases in monocyte inflammatory responses and sepsis
Jackson, S. K., & Parton, J. (2004) · Immunobiology · doi:10.1016/j.imbio.2004.04.006 · Cited by 10
Engervall, P., Björkholm, M., Granström, M., et al. (1997) · Infection · doi:10.1007/bf02113498 · Cited by 10
Roy, D. L., Crouzier, C., Dho-Moulin, M., et al. (1995) · Research in Microbiology · doi:10.1016/0923-2508(96)80894-1 · Cited by 9
Sykes, B. W., Furr, M., & Giguère, S. (2005) · PubMed · Cited by 9
The Role of IFN-γ in Surgical Patients
Schinkel, C. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003322225998 · Cited by 9
“(22,24) In clinical trials, in vivo immunomodulation with rHuIFN-g is safe and effective in terms of in vitro findings.”
Doherty, G. M., Alexander, H. R., Merino, M. J., Venzon, D. J., & Norton, J. A. (1996) · Annals of Surgical Oncology · doi:10.1007/bf02305801 · Cited by 9
Self-citationEFFECTS OF REPEATED INHALATION EXPOSURE TO MICROVESICLE-BOUND ENDOTOXIN
Skórska, C., Sitkowska, J., Burrell, R. E., et al. (1996) · Annals of Agricultural and Environmental Medicine · Cited by 9
IFN‐γ +874T/A polymorphism increases susceptibility to post‐traumatic osteomyelitis
Zhao, X., Jiang, N., Hu, Y., et al. (2019) · International Journal of Immunogenetics · doi:10.1111/iji.12462 · Cited by 8
Kim, J. G., & Hahn, Y. S. (2000) · Immunological Investigations · doi:10.3109/08820130009060866 · Cited by 8
Heat Shock Proteins in the Regulation of the Apoptotic Response
Ayala, A., Chung, C., & Chaudry, I. H. (1998) · Sepsis · doi:10.1023/a:1009763402040 · Cited by 8
de Metz, J., Romijn, J. A., Endert, E., Ackermans, M. T., Weverling, G. J., Busch, O. R., Wit, L., Gouma, D. J., ten Berge, I. J. M., & Sauerwein, H. P. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00090.2002 · Cited by 7
Cytokines and Escherichia coli Sepsis
Kaech, C., Bochud, P., & Calandra, T. (2006) · EcoSal Plus · doi:10.1128/ecosalplus.8.8.15 · Cited by 7
Exogenous VIP limits zymosan-induced generalized inflammation (ZIGI) in mice
Ivanovska, N., Kalfin, R. E., Lazarova, M. I., et al. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.04.003 · Cited by 7
Albright, J. W., Albright, J. W., Stewart, M. J., et al. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.5.636 · Cited by 7
The systemic inflammatory response syndrome
Sherwood, E. R., & Traber, D. L. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3274-8.50025-8 · Cited by 7
Proinflammatory Cytokines in AntilipopolysaccharideImmunity Against Klebsiella Infections
Rukavina, T., Vasiljev, V., & Tićac, B. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.88 · Cited by 7
Petrov, A. B., Kolenko, V. M., Koshkina, N. V., et al. (1994) · Vaccine · doi:10.1016/0264-410x(94)90174-0 · Cited by 7
Bucklin, S. E., Russell, S. W., & Morrison, D. C. (1994) · Journal of Endotoxin Research · doi:10.1177/096805199400100108 · Cited by 7
Wang, H. R., Zhang, Y., Mo, Y., Zhang, Z., Chen, R., Lu, X. B., & Huang, W. (2024) · Communications Biology · doi:10.1038/s42003-024-06566-y · Cited by 6
“However, considering that high-dose cytokines (e.g., IL-2, IL-12, TNF, and IFNG) treatments may cause cytokine storm, subsequently induce severe side effects and multi-organ dysfunction in animal models 47 – 49 .”
Beigneux, A. P., Huang, J. L., Contel, C. L., et al. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.359 · Cited by 6
Interferon-g: A historical perspective
Billiau, A., & Matthys, P. (2009) · Cited by 5
Zhang, H., & Han, K. (2020) · STEMedicine · doi:10.37175/stemedicine.v1i4.65 · Cited by 5
Huang, J.-H., Lin, Y. ‐., Lai, Y., et al. (2006) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2006.00266.x · Cited by 5
Possibilities and problems of cytokine measurements
Cavaillon, J. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8755-7_6 · Cited by 5
The Generation of Inflammatory Responses
Heumann, D., PIERREGLAUSER, M., & Calandra, T. (2002) · Elsevier eBooks · doi:10.1016/b978-012677530-3/50252-x · Cited by 4
Current Concepts of the Inflammatory Response
Sherwood, E. R. (2002) · ASA Refresher Courses in Anesthesiology · doi:10.1097/00126869-200230010-00015 · Cited by 4
Shvedova, A. A., Satoh, T., Tollerud, D. J., et al. (1996) · Experimental Lung Research · doi:10.3109/01902149609050844 · Cited by 4
Proinflammatory and Anti-Inflammatory Cytokines as Mediators of Gram-Negative Sepsis
Cavaillon, J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-309-5_4 · Cited by 4
Molecular Mediators: Cytokines
Cavaillon, J. (2015) · Reviews in Cell Biology and Molecular Medicine · doi:10.1002/3527600906.mcb.200400134.pub2 · Cited by 4
Pathological Aspects of Platelet-Activating Factor (PAF)
von Bruchhausen, F. (1997) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60639-7_28 · Cited by 4
The Protective Role of Interleukin-10 in Sepsis
Marchant, A., Vincent, J., & Goldman, M. (1994) · Springer eBooks · doi:10.1007/978-3-642-85068-4_5 · Cited by 3
Cytokine release induced by killed bacteria associated with anti-IFN-γ antibody in infection
Sinha, A., & Bagchi, A. K. (2005) · Cytokine · doi:10.1016/j.cyto.2005.03.004 · Cited by 3
The role of the spleen in laparoscopy-associated inflammatory response
Bachman, S. L., Hanly, E. J., Saad, D. F., et al. (2005) · Surgical Endoscopy · doi:10.1007/s00464-004-8820-2 · Cited by 3
“INF-c is necessary for the toxic and lethal effects of LPS and TNF-a it appears to be an obligatory comediator of TNF-a activity [6].”
BackgroundRaspé, C., Czeslick, Leimert, Rossberg, Hofmann, Simm, Weimann, & Sablotzki (2013) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s41683 · Cited by 3
L'inflammation: un équilibre précaire entre cytokines pro- et anti-inflammatoires
Cavaillon, J. (1995) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(95)80357-2 · Cited by 3
Use of fixed cells in cell contact-dependent cytotoxicity assays for TNF: A cautionary report
Watts, A. D., Onier-Cherix, N., Hunt, N. H., et al. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00046-0 · Cited by 3
The systemic inflammatory response syndrome
Sherwood, E. R., & Traber, D. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2786-9.00021-7 · Cited by 3
T cells and malarial pathology
Clark, I. A., & Rockett, K. A. (1994) · Research in Immunology · doi:10.1016/s0923-2494(94)80174-6 · Cited by 3
Effect of Polyclonal Anti-TNFα Antibody on Endotoxic Shock in Suckling Rats
Bhola, M., Gotō, M., Chen, H. Y., et al. (2000) · Neonatology · doi:10.1159/000014272 · Cited by 2
Platelet-Activating Factor and the Production of Human Interferon-γ
Yousefi, S., Vaziri, N. D., Carandang, G., et al. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.107 · Cited by 2
Wang, C., Kuzma, M., Qiu, G., et al. (2003) · Experimental Lung Research · doi:10.1080/01902140303779 · Cited by 2
Interaction of bacteria and airway epithelial cells
van Alphen, L. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09071342 · Cited by 2
Modulation of NK Cell Properties by ESKAPE Group Bacteria
Владимировна, Г. П., Juchina, V., Tyshchuk, E. V., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178449 · Cited by 1
“The production of TNF α and IFN γ by NK cells is closely linked: both cytokines regulate the activity of the target cell [61] and can stimulate the synthesis of each other [62].”
Médiateurs de l’inflammation au cours du sepsis
Cavaillon, J. (2011) · Springer eBooks · doi:10.1007/978-2-8178-0064-6_2 · Cited by 1
Marley, S. B., Hadley, C. L., & Wakelin, D. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb06660.x · Cited by 1
The role of the spleen in laparoscopy-associated inflammatory response
Bachman, S. L., Hanly, E. J., Saad, D. F., et al. (2005) · Surgical Endoscopy · doi:10.1007/s00464-005-8820-x · Cited by 1
Cavaillon, J. (2006) · Springer eBooks · doi:10.1007/2-287-27496-0_2 · Cited by 2
Kabanov, D. S., Rykov, V. A., Prokhorenko, S. V., Murashev, A. N., & Прохоренко, И. Р. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918070088 · Cited by 1
Revisiting Metchnikoff's work in light of the COVID-19 pandemic
Cavaillon, J., & Levin, J. (2022) · Innate Immunity · doi:10.1177/17534259211070663 · Cited by 1
FLIP-expressing myeloid cells as driver of systemic immune disorders
Atanasio, A., Rizzini, D., & Ugel, S. (2022) · Journal of Cellular Immunology · doi:10.33696/immunology.4.138
“The analysis revealed a conserved arrangement of myeloid cells between the two different species, and, among myeloid populations, monocytes presented a similar profile of active inflammatory pathways such as tumor necrosis factor (TNF)-α via NF-κB and JAK-STAT3 signaling.”
BackgroundChizzonite, R., Gubler, U., Magram, J., & STERN, A. S. (1998) · Elsevier eBooks · doi:10.1016/b978-012498340-3/50013-0 · Cited by 5
glucose and fat metabolism in post-operative patients
de Metz, J., Romijn, J. A., Endert, E., et al. (2003)
Type I Interferon Signaling in Shaping Cellular Innate and Adaptive Immunity to Viral Infection
Biron, C. A. (2014) · ASM Press eBooks · doi:10.1128/9781555815561.ch10
Involvement of Pro- and Anti-Inflammatory Cytokines in Sepsis
Cavaillon, J., & Adib‐Conquy, M. (2002) · Springer eBooks · doi:10.1007/0-306-47664-9_10
Neurochemical mechanisms mediating LPS-induced anorexia
Kopf, B. S. (2009) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005901956
Schinkel, C., Zedler, S., Faist, E., et al. (2002) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-002-0268-9
TUMOR NECROSIS FACTOR, OTHER CYTOKINES AND
Tracey, K. J., & Cerami, A. (1993)
Faist, E., Schinkel, C., & Kim, C. (2000) · Springer eBooks · doi:10.1007/978-1-4612-1222-5_53
Sykes, B. W. (2003) · VTechWorks (Virginia Tech)
Regulation of Induced Nitric Oxide Synthase in Vascular Smooth Muscle Cells by Glucocorticoids
Alsugoor, M. H. (2018) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.19617
“…work as an endotoxin, effectively induce inflammation and immune response in cells, and induce many mediators involved in septic shock (Raetz & Whitfield, 2002); and • IFN-γ, a cytokine produced after viral or bacterial infection, though its activity is not fully understood (Doherty et al., 1992).”
BackgroundAnticytokine Therapies in Patients with Severe Sepsis and Septic Shock
Bochud, P., Glauser, M. P., & Calandra, T. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-309-5_26
Deng, M. C.-H. K. (1997) · Steinkopff eBooks · doi:10.1007/978-3-642-48012-6_5
Cytokines in the treatment of fungal infections
Kullberg, B. J., & Wout, J. W. V. ’. (1994) · Springer eBooks · doi:10.1007/978-94-011-0233-9_7
(1994) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.3.6.673
Molecular Mediators: Cytokines
Cavaillon, J. (2006) · Encyclopedia of Molecular Cell Biology and Molecular Medicine · doi:10.1002/3527600906.mcb.200400134
Innate immune responses in the lung and liver
Dajani, R. B. (2005) · doi:10.17077/etd.3ijtk1ft
“IFN-γ is responsible for inducing significant cytotoxicity during the course of endotoxemia (82).”
Qui est l'assassin au cours du sepsis? : l'inflammation ou la prolifération bactérienne ?
de Tymowski, C. (2020) · theses.fr (ABES) · doi:10.70675/ed19121fza61fz403czb053z70b4c1f5a3a6
Bourgoin, P. (2020) · theses.fr (ABES) · doi:10.70675/4284bec3zae20z4f87za718z2b50276f2482
Metadata
- Authors
- Doherty, G. M., Lange, J. R., Langstein, H. N., Alexander, H. R., Buresh, C. M., & Norton, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-09-01
- Volume
- 149
- Issue
- 5
- Pages
- 1666-1670
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1946578458
- Cited by
- 300
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 1 · 2022: 7 · 2021: 6 · 2020: 6 · 2019: 3 · 2018: 4 · 2016: 2 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 6
- FWCI
- 7.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- interferon-gamma, TNF-α, endotoxemia, cytokine synergy, anti-TNF-alpha antibody, anti-IFN-gamma antibody, interleukin-6, serum cytokine levels, endotoxin tolerance, sepsis
- MeSH terms
- Animals, Antibodies, Endotoxins, Female, Interferon-gamma, Lipopolysaccharides, Mice, Inbred C3H, Rabbits, Tumor Necrosis Factor-alpha, Interleukin-6, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review